CHICAGO - Cosmos Health Inc. (NASDAQ:COSM), a global healthcare group with a market capitalization of $15.11 million, is ...

For Tammy Gusher Delgado, 56, the decision to join a clinical trial was clear. With a recent multiple sclerosis diagnosis and a clinical trial offering either the study drug or an approved ...

AI was a key theme at OCT Medical Devices 2025, yet human sensibility appears to be the true differentiator in clinical trial ...

Medical devices are revolutionizing healthcare ... from the beginning of development and is a priority throughout this phase. Manufacturers that treat security as a core business initiative ...

DJ Affluent Medical announces 10th ... 100% successful activation of implanted devices to date. -- Good clinical safety profile observed during pilot phase. -- Promising preliminary performance ...

President and CEO of KORU Medical. “Assuming successful completion and results from this Phase III clinical trial, this drug’s expanded indication will give us access to a new patient base and ...

Creative Medical Technology (CELZ) announced initial data from the first cohort of its ongoing Phase 1/2 clinical trial of CELZ-201-DDT, the Company’s proprietary stem cell-based therapeutic for ...

of Urology, Cochin Hospital, Paris, and member of the Scientific Board of Affluent Medical. The results from this initial clinical phase will guide the execution of the pivotal phase, scheduled to ...

LaSalle Parish voters will join all of Louisiana March 29 to decide the fate of four constitutional amendments. The amendments are the result of actio... Louisiana students have achieved some of the ...

LIFE SAVING MEDICAL DEVICE SYSTEMS. THIS IS A CRITICAL CARE LINE. THIS IS WHERE WE MAKE OUR BLOOD GAS ANALYZERS. MARK OLSON IS THE CHIEF MANUFACTURING OFFICER FOR WARFARIN. THIS MASSACHUSETTS ...